INIS
cancer
100%
receptors
74%
central nervous system
55%
pain
52%
nervous system diseases
52%
rats
52%
diseases
38%
brain
35%
flavonoids
35%
toxicity
33%
neurons
31%
tumors
31%
reviews
30%
dendrites
26%
evaluation
26%
validation
26%
ethanol
26%
chemotherapy
26%
attitudes
26%
sims
26%
plasticity
26%
dimensions
26%
stimuli
21%
patients
21%
molecules
21%
metabolites
19%
regulations
18%
correlations
17%
males
17%
females
17%
roots
17%
pharmaceuticals
13%
medicine
13%
drugs
13%
genes
12%
guidelines
12%
metabolism
10%
glioblastomas
9%
inflammation
9%
antidepressants
8%
kinetics
8%
people
8%
control
8%
branching ratio
8%
comparative evaluations
8%
aromatics
8%
liver
8%
processing
8%
analgesics
8%
least square fit
8%
approximations
8%
norm
8%
kidneys
8%
terpenes
8%
errors
8%
tools
8%
in vivo
8%
kinases
8%
in vitro
8%
communities
8%
safety
8%
hippocampus
8%
levels
8%
computer codes
8%
size
8%
economics
8%
reliability
8%
therapy
8%
cell cycle
7%
variations
7%
oxidation
7%
cations
7%
tissues
7%
applications
6%
inventions
6%
modulation
5%
therapeutic agents
5%
stability
5%
synthesis
5%
junctions
5%
lipids
5%
growth factors
5%
diffusion
5%
distribution
5%
modifications
5%
catabolism
5%
ions
5%
concentration
5%
blocking
5%
abundance
5%
proteins
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
67%
Flavonoid
39%
Diseases
38%
Receptor
33%
Parkinson's Disease
30%
Molecular Target
30%
Toxicity
29%
Lippia
26%
Drug Delivery Vehicle
26%
Cognitive Defect
26%
Chemotherapy
26%
Wistar Rat
26%
Cancer Pain
26%
Passiflora edulis
26%
Sphingolipid
26%
Intracranial Tumor
26%
Neuroprotection
26%
Connexin 30
26%
Connexin 36
26%
Gap Junction Protein
26%
Connexin 43
26%
Degenerative Disease
26%
Transient Receptor Potential Channel
19%
Antidepressant
13%
Phosphatidylinositol 3 Kinase
13%
Analgesic Agent
13%
Pathophysiology
13%
Glioblastoma
12%
Neurotransmitter
11%
Acute Toxicity Study
10%
Alzheimer's Disease
8%
Outer Membrane Protein A
8%
Neuroblastoma
8%
Biological Activity
6%
Drug Development
6%
Neurotoxicity
6%
Hyperalgesia
6%
Tumor Microenvironment
6%
Allodynia
6%
Growth Factor
6%
Desensitization
6%
Plant Extract
6%
Phospholipidosis
5%
Sphingosine
5%
Lethality
5%
No-Observed-Adverse-Effect Level
5%
Kidney Calcification
5%
Monocytopenia
5%
Eosinopenia
5%
Passifloraceae
5%
Passiflora
5%
Keyphrases
Drug Delivery Vehicle
26%
Neurobiological Mechanisms
26%
Chemotherapy-related Cognitive Impairment
26%
Sphingolipids
26%
Subacute Toxicity
26%
Connexin36
26%
Brain Tumor
26%
Connexin 43 (Cx43)
26%
Dendritic Complexity
26%
Rat Cortical Neurons
26%
Molecular Targets
26%
TRP Channels
26%
Male Rats
19%
Transient Receptor Potential Vanilloid 1 (TRPV1)
17%
Anxiolytic
13%
Phosphatidylinositol 3-kinase Pathway
13%
Dendritic Branching
13%
Synthetic Flavonoid
13%
Pharmaceutical Potential
13%
Natural Flavonoids
13%
Biopharmaceutical Development
13%
Cognitive Processing
13%
Aromatic Plants
13%
Neural Plasticity
13%
Plant Therapeutics
13%
Sholl Analysis
13%
Noxious Stimuli
10%
Nanovehicles
8%
Software Factors
8%
Least Squares Estimator
8%
Optimal Reliability
8%
Root Mean Square Residual
8%
Statistical Fit
8%
Attitudes toward Cancer
8%
Weighted Least Squares
8%
Desensitization
8%
Antinociceptive
8%
Inflammatory Mediators
8%
Microenvironment
8%
Hyperalgesia
8%
Sensory Stimuli
8%
Patients with Cancer
8%
Tumor Microenvironment
8%
Intracellular Signaling
8%
Allodynia
8%
Nociceptive Stimulus
8%
Peripheral Sensitization
8%
Boolean Formulas
6%
Memory-based Learning
6%
Healthy Cells
6%
Chemotherapy-induced
6%
Low-toxic
6%
Indirect Mechanism
6%
Tumor Chemotherapy
6%
Sub-acute Toxicity Study
6%
Regulatory Guidelines
6%
Organization for Economic Cooperation and Development
6%
Non-adverse
6%
Liver Function
6%
NOAEL
6%
Monocytopenia
6%
Eosinopenia
6%
Nephrocalcinosis
6%
Subtropical Region
6%
Medicinal Importance
6%
Development Guidelines
6%
Pain Treatment
5%
Pressure Stimulus
5%
Pain Sensation
5%
Osmotic Pressure
5%
Heart-lung
5%
Heart-brain
5%
Nociception
5%
Cation Channel
5%
Sphingosine
5%
Sphingolipidoses
5%
Sphingolipid Metabolism
5%
Lipid Derived
5%
Regulatory Pathways
5%
Broad Network
5%